BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...
WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), tod...
Samsung Biologics reported third-quarter revenue of KRW 1.49 trillion and operating profit of KRW 640 billion, supported...
QIAGEN and EQT Private Equity agree on an all-cash public takeover offer for all outstanding QIAGEN shares at an off...
Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As a...
Purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of approximat...
Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...
Artificial intelligence is changing how researchers identify therapeutic targets and design molecules, but its lasting v...
Cell and gene therapies may now be moving faster than the manufacturing networks built to deliver them. The Alliance of...
Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and ge...
Sartorius and France-based MAbSilico have entered a non-exclusive collaboration combining AI-powered predict...
Thermo Fisher Scientific has launched the Thermo Scientific™ Nicolet™ RaptIR™ X FTIR Microscope, expan...
As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they ...
QIAGEN N.V. has announced the launch of QIAmini, a compact automated sample preparation system designed to give research...
Eppendorf is expanding its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, floor-standing h...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial evaluating leriglitazo...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
Africa carries the majority of the global sickle cell disease burden, yet care across many health systems remains fragme...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Akeso has launched a Phase II clinical study in the United States evaluating a cadonilimab-based combination regimen for...
HUYABIO International has reported statistically significant and clinically meaningful topline Phase 3 results for HBI-8...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
